HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Section

People

Executive moves at pharma, PBM, payer, and GPO organizations

GSK Names First Chief Diversity Officer Amidst Regulatory Challenges and Product Pipeline Expansion: Strategic Implications
People
GSK’s new Chief Diversity Officer arrives as the company wrangles with EMA and FDA scrutiny and ramps up spend…
Apr 9, 2026
AstraZeneca Names New CFO as $16B in Annual Revenue Nears Patent Cliff: What Happens Next?
People
AstraZeneca brings in a new CFO just as nearly one-third of its revenues risk generic erosion. Investors are w…
Mar 10, 2026
The Revolving Door Between PBMs and Regulators: Career Paths That Shape Drug Pricing Policy
People
From CMS chiefs to PBM officers, the same executives alternate between regulating and running pharmacy benefit…
Feb 10, 2026
Three PBM Executives Exit in One Week: What the Talent Shift Signals
People
A wave of senior departures at OptumRx, Caremark, and ESI points to structural change in the PBM business mode…
Mar 22, 2025
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.